Annual Accounts Payable
$3.69 M
+$479.00 K+14.89%
December 31, 2023
Summary
- As of February 10, 2025, CGTX annual accounts payable is $3.69 million, with the most recent change of +$479.00 thousand (+14.89%) on December 31, 2023.
- During the last 3 years, CGTX annual accounts payable has risen by +$1.69 million (+84.47%).
- CGTX annual accounts payable is now -11.35% below its all-time high of $4.17 million, reached on December 31, 2021.
Performance
CGTX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$1.90 M
-$1.14 M-37.54%
September 30, 2024
Summary
- As of February 10, 2025, CGTX quarterly accounts payable is $1.90 million, with the most recent change of -$1.14 million (-37.54%) on September 30, 2024.
- Over the past year, CGTX quarterly accounts payable has dropped by -$964.00 thousand (-33.72%).
- CGTX quarterly accounts payable is now -76.57% below its all-time high of $8.09 million, reached on September 30, 2022.
Performance
CGTX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
CGTX Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +14.9% | -33.7% |
| 3 y3 years | +84.5% | -33.7% |
| 5 y5 years | +56.8% | -33.7% |
CGTX Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -11.3% | +14.9% | -76.6% | at low |
| 5 y | 5-year | -11.3% | +84.5% | -76.6% | at low |
| alltime | all time | -11.3% | +84.5% | -76.6% | at low |
Cognition Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.90 M(-37.5%) |
| Jun 2024 | - | $3.03 M(+15.0%) |
| Mar 2024 | - | $2.64 M(-28.6%) |
| Dec 2023 | $3.69 M(+14.9%) | $3.69 M(+29.2%) |
| Sep 2023 | - | $2.86 M(-29.6%) |
| Jun 2023 | - | $4.06 M(+30.1%) |
| Mar 2023 | - | $3.12 M(-3.0%) |
| Dec 2022 | $3.22 M | $3.22 M(-60.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $8.09 M(+144.8%) |
| Jun 2022 | - | $3.30 M(-17.3%) |
| Mar 2022 | - | $4.00 M(-4.1%) |
| Dec 2021 | $4.17 M(+108.1%) | $4.17 M(+50.2%) |
| Sep 2021 | - | $2.77 M(-24.1%) |
| Jun 2021 | - | $3.66 M(+14.7%) |
| Mar 2021 | - | $3.19 M(+59.1%) |
| Dec 2020 | $2.00 M(-15.0%) | $2.00 M |
| Dec 2019 | $2.36 M | - |
FAQ
- What is Cognition Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Cognition Therapeutics?
- What is Cognition Therapeutics annual accounts payable year-on-year change?
- What is Cognition Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Cognition Therapeutics?
- What is Cognition Therapeutics quarterly accounts payable year-on-year change?
What is Cognition Therapeutics annual accounts payable?
The current annual accounts payable of CGTX is $3.69 M
What is the all time high annual accounts payable for Cognition Therapeutics?
Cognition Therapeutics all-time high annual accounts payable is $4.17 M
What is Cognition Therapeutics annual accounts payable year-on-year change?
Over the past year, CGTX annual accounts payable has changed by +$479.00 K (+14.89%)
What is Cognition Therapeutics quarterly accounts payable?
The current quarterly accounts payable of CGTX is $1.90 M
What is the all time high quarterly accounts payable for Cognition Therapeutics?
Cognition Therapeutics all-time high quarterly accounts payable is $8.09 M
What is Cognition Therapeutics quarterly accounts payable year-on-year change?
Over the past year, CGTX quarterly accounts payable has changed by -$964.00 K (-33.72%)